Bionano Genomics announces the publication of a comprehensive report
Key findings from the evaluation of 59 heme samples and 10 controls: OGM detected 162/164…
Browsing: risks uncertainties
Hydrogen’s First Green Hydrogen Van to Begin Demonstration Testing in June | Taiwan News
Vancouver, British Columbia – Newsfile Corp. – March 15, 2022 – First Hydrogen Corp. (TSXV:…
PharmAla Biotech signs a contract with InterVivo Solutions to validate new MDMA analogues
Start of proof-of-concept preclinical animal research on PharmAla’s patented ABA seriesprogrammed MDXX compoundsVANCOUVERBEFORE CHRIST ,…
PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation
TORONTO, Feb. 16 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Eyenovia concludes a Type A meeting with the FDA regarding
NEW YORK, 08 Feb. 10, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic…
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Drug Candidate for Multiple Myeloma
Lonza will manufacture drug substance for clinical supply of HaemaLogiX’s lead drug candidate for multiple…
Marinomed announces preliminary sales for 2021, the highest in its history
DGAP-News: Marinomed Biotech AG / Tag(s): Preliminary results27.01.2022 / 07:45 The issuer is solely responsible…
Airgain® Announces Grant of Incentives Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO–(BUSINESS WIRE)–Airgain, Inc. (NASDAQ:AIRG)a leading provider of advanced wireless connectivity solutions and technologies used…
.jpg){kind=logo}
Natera announces expansion in early cancer detection and screening
[ad_1] AUSTIN, Texas – (COMMERCIAL THREAD) -Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic…
HTG Moves to Next Phase of HTP Product Development
[ad_1] TUCSON, Ariz., December 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM)…
United States Food and Drug Administration (FDA) Responds to TherapeuticsMD Request to Revise Certain Manufacturing Test Limits for ANNOVERA®
[ad_1] BOCA RATON, Florida – (COMMERCIAL THREAD) – TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TXMD†or the…
GSK provides update on manufacturing operations in Singapore
[ad_1]SINGAPORE, December 8, 2021 / PRNewswire / – GSK today announced that it will cease…
Sorrento announces the publication of a series of novels
[ad_1] A representative of the novel MPro series of inhibitors, MPI8, doubly inhibits MPro and…
Validation process begins for Mullen’s Class 2 EV utility vans
[ad_1]Initial validation and evaluation of Class 2 cargo vans has begun at AMEC’s ​​facilities outside…
AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing
[ad_1] AWS Works With Pfizer To Support Faster Innovation And Improved Clinical Manufacturing Operations To…
Over 8,000 people attend Boosh-sponsored planted exhibit in Vancouver
[ad_1]Vancouver, British Columbia – (Newsfile Corp. – November 25, 2021) – Boosh Plant-Based Brands Inc.…
Entheon Biomedical provides update on clinical and preclinical DMT programs
[ad_1]Shipment of GMP DMT, in vitro HERG and Genotox testing completed and in vivo toxicity…
Todos Medical Announces Addition of Semi-Quantitative Titer Claims to Emergency Use Authorization for cPass Neutralizing Antibody Test
[ad_1] · EUA reauthorization extends beyond initial qualitative detection request · CEO to appear on…
Bloomios Shareholder Update and Growth Strategy
[ad_1] Bloomios Shareholder Update and Growth Strategy Tweet this Bloomios went public in April 2021.…
Manufacturing Grants Program Boosts Shop Floor Innovation |
[ad_1]There’s a lingering buzz in the air in the workshops of Connecticut manufacturers, with people…
Ginkgo Bioworks Launches Cellular Development Kit Service for Standardized, Low-Cost Entry to Its Cellular Programming Platform
[ad_1] BOSTON, November 11, 2021 / PRNewswire / – Ginkgo Bioworks (NYSE: DNA), the leading…
ETC Announces Notice of Annual Meeting of Shareholders
[ad_1] SOUTHAMPTON, Pa., November 09, 2021 (GLOBE NEWSWIRE) – Environmental Tectonics Society (OTC Pink: ETCC)…
Eyenovia Announces First Patient Enrolled in MicroLine’s Phase 3 VISION-2 Presbyopia Trial – Form 8-K
[ad_1] Eyenovia Announces First Patient Enrolled in MicroLine Phase 3 VISION-2 Trial for Presbyopia Vision-2…
Volition Veterinary Presents Two Posters at 2021 Veterinary Cancer Society Conference
[ad_1] Dr. Tom butera, President and CEO of Volition Veterinary Diagnostics Development, LLC said, “be…
Sera Prognostics announces the publication of the clinical validation of the PreTRM® threshold for clinical action
[ad_1] SALT LAKE CITY, November 3, 2021 / PRNewswire / – Serum prognosis Inc., The…
Livent announces LIOVIX ™, a proprietary lithium metal product that can improve the performance, safety and durability of lithium-ion batteries
[ad_1] PHILADELPHIA CREAM, November 1, 2021 / PRNewswire / – – Allows higher capacity and…
Element Nutritional Sciences Announces Rejuvenate ™ Now Available in Fortinos Supermarkets
[ad_1]Rejuvenate â„¢ will be available in 23 stores in OntarioFortinos is a subsidiary of Loblaw,…
Turning Point Therapeutics Presents First Clinical Data From Repotrectinib From Care Study in Pediatric and Young Adult Patients at SIOP 2021 Virtual Congress
[ad_1]SAN DIEGO, Oct 23, 2021 (GLOBE NEWSWIRE) – Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Cybin files international patent application covering psychedelic delivery methods
[ad_1]TORONTO, October 12, 2021- (COMMERCIAL THREAD) -Cybin Inc. (NEO: CYBN) (AMERICAN NYSE: CYBN) (“Cybine”or the”Society”),…
Cybin announces other landmark achievements of Adelia
[ad_1] TORONTO – (COMMERCIAL THREAD) -Cybin Inc. (NEO: CYBN) (AMERICAN NYSE: CYBN) (“Cybine”or the”Society”), a…
Radient Technologies Inc.Announces First Quarter 2022 Financial Results
[ad_1] Enter Wall Street with StreetInsider Premium. Claim your 1-week free trial here. – The…
Biophytis to host virtual KOL event on Sarconeos (BIO101) on its main projects in COVID-19 and sarcopenia
[ad_1] PARIS and CAMBRIDGE, Mass., 06 Oct 2021 (GLOBE NEWSWIRE) – Biophytis SA (NasdaqCM: BPTS,…
Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma | Illinois
[ad_1] CHICAGO – (BUSINESS WIRE) – October 5, 2021–Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company…
/cloudfront-us-east-1.images.arcpublishing.com/gray/SBHL6Z5KJ4LXK4QP6254L7WMME.jpg)
Valens Company Signs Six Manufacturing Partnerships and Company Update
[ad_1]KELOWNA, BC, October 5, 2021 / PRNewswire / – The Valens Company Inc. (TSX: VLNS)…
Mountain Valley MD Holdings Provides Business Update,
[ad_1] TORONTO, September 29, 2021 (GLOBE NEWSWIRE) – Mountain Valley MD Holdings Inc. (the “Society”…
Biophytis to Present Full Results of Sarconeos (BIO101) Phase 2b SARA-INT Trial in Sarcopenia at the 11th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) from September 29 to October 2, 2021
[ad_1]PARIS and CAMBRIDGE, Mass., Sep 29, 2021 (GLOBE NEWSWIRE) – Biophytis SA (NasdaqCM: BPTS, Euronext…
Relief reports that its US collaborative partner announced improved one-year survival in highly comorbid COVID-19 patients treated with ZYESAMITM (RLF-100TM / aviptadil)
[ad_1]GENEVA, SWITZERLAND / ACCESSWIRE / September 28, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: RLF)…
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal 2021 Financial Results and Business Update
[ad_1] AUSTIN, Texas – (COMMERCIAL THREAD) – Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical…
Integer to build new innovation and manufacturing facility in Galway, Ireland
[ad_1]Expansion to significantly increase Integer’s presence and capabilities in Galway; Means continued growth and a…
G6 Materials announces live webinar hosted by Red Cloud on September 23, 2021
[ad_1] Daniel Stolyarov, President and CEO, will provide an update on the company following its…
The Valens Company Announces Strategic Distribution Agreement with APOTEKA SRL, Subsidiary of GFI Costa Rica and Provides Update on Australia
[ad_1] The APOTEKA partnership offers a strategic entry to the Valens brands through central America…
Natera Announces Use of Signatera® as a Companion Diagnostic in GSK’s ZEST Phase III Trial for Niraparib in Early-Stage Breast Cancer
[ad_1] AUSTIN, Texas, August 4, 2021 / PRNewswire / – Natera, Inc. (NASDAQ: NTRA), a…
Sorrento Mexico and the National Institute of Genomics
[ad_1] After COVI-STIX â„¢ (COVID-19 VIRUS RAPID ANTIGEN DETECTION TEST) obtained the Emergency Use Authorization…
Pharvaris Presents Oral PHA121 Clinical Data in Support of Prophylactic Treatment of … | New
[ad_1] ZUG, Switzerland, July 10, 2021 (GLOBE NEWSWIRE) – Pharvaris (Nasdaq: PHVS), a clinical-stage company…